Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4437748)

Published in Infect Agent Cancer on May 14, 2015

Authors

Luc Magloire Anicet Boumba1, Samira Zoa Assoumou2, Lahoucine Hilali3, Jean Victor Mambou4, Donatien Moukassa5, Mustapha Moulay Ennaji6

Author Affiliations

1: Laboratoire de Virologie, Microbiologie et Qualité/ETB, Faculté des Sciences et Techniques de Mohammedia, Université Hassan II Casablanca, B.P. 146, 20650 Mohammedia, Maroc ; Laboratoire d'Agroalimentaire et Santé, Département de Biologie Appliquée, Faculté des Sciences et Techniques, Université Hassan 1er Settat B.P. 577 Settat, Mohammedia, Maroc ; Laboratoire d'Analyses Médicales et Morphologiques, Hôpital Général de Loandjili, B.P. 8122, Pointe-Noire, Congo.
2: Laboratoire de Virologie, Microbiologie et Qualité/ETB, Faculté des Sciences et Techniques de Mohammedia, Université Hassan II Casablanca, B.P. 146, 20650 Mohammedia, Maroc ; Laboratoire d'Agroalimentaire et Santé, Département de Biologie Appliquée, Faculté des Sciences et Techniques, Université Hassan 1er Settat B.P. 577 Settat, Mohammedia, Maroc.
3: Laboratoire d'Agroalimentaire et Santé, Département de Biologie Appliquée, Faculté des Sciences et Techniques, Université Hassan 1er Settat B.P. 577 Settat, Mohammedia, Maroc.
4: Centre Médico-social de la Mairie Centrale de Pointe-Noire, B.P. 383, Place de la Liberté, 97116 Pointe-Noire, Congo.
5: Laboratoire d'Analyses Médicales et Morphologiques, Hôpital Général de Loandjili, B.P. 8122, Pointe-Noire, Congo.
6: Laboratoire de Virologie, Microbiologie et Qualité/ETB, Faculté des Sciences et Techniques de Mohammedia, Université Hassan II Casablanca, B.P. 146, 20650 Mohammedia, Maroc.

Articles cited by this

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47

The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90

MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

Classification of papillomaviruses. Virology (2004) 14.16

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86

Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44

Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases. Mol Biol Evol (1992) 5.99

Human papillomaviruses in the pathogenesis of anogenital cancer. Virology (1991) 5.74

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell (1991) 3.58

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13

Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol (2000) 1.78

Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res (1998) 1.75

Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer (2006) 1.65

Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol (2008) 1.52

High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer (2007) 1.47

Human papillomavirus genome variants. Virology (2013) 1.45

Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol (1997) 1.41

Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol (2012) 1.26

Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25

Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol (1996) 1.21

Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol (2008) 1.19

HPV16 genetic variation and the development of cervical cancer worldwide. Br J Cancer (2012) 1.13

Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes (1994) 1.00

HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol (2009) 0.95

Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol (1997) 0.95

Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One (2014) 0.92

Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment. Biochem Pharmacol (2010) 0.92

Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res (2007) 0.91

E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology (2010) 0.90

Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol (2006) 0.90

The uganda study on HPV variants and genital cancers. J Clin Virol (2000) 0.89

Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa. Int J Gynecol Cancer (2006) 0.86

Identification of multiple genital HPV types and sequence variants by consensus and nested type-specific PCR coupled with cycle sequencing. Pathology (2000) 0.83

Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain. PLoS One (2014) 0.82

Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. New Microbiol (2007) 0.80

Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women. BMC Public Health (2014) 0.78

Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16. Lancet (1997) 0.76